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Background: Direct stenting is commonly used during percutaneous coronary intervention for acute myocardial infarction (MI) to prevent distal 
embolization. However, no guideline recommendations exist regarding direct stenting (DS). We sought to compare direct stenting and conventional 
stenting (CS) in patients presenting with an acute MI. 
Methods: Studies were identified from EMBASE, MEDLINE, and CENTRAL. To be included, randomized controlled trials must have assessed DS and 
CS in patients with an acute MI. Data was extracted and articles were critically appraised by two authors. Fixed effects model was used with Peto 
odds ratios(OR). 
Results: Five trials met the eligibility criteria. Of 754 patients, 605 (80%) presented with a MI, and 51 (6.7%) presented with unstable angina. In 
hospital cardiovascular death occurred in 0.27% (1/375) in the DS group, and 2.11% (8/379) in the CS group (OR = 0.21, 95% CI = 0.06-0.77, p < 
0.02, I2 = 0%). In hospital myocardial infarction occurred in 0.57% (2/350) in the DS group, and 1.69% (6/354) in the CS group (OR = 0.38, 95% 
CI = 0.09-1.51, p = 0.17, I2 = 7%). ST-segment resolution occurred in 68.9% (146/212) in the DS group versus 60.2% (127/211) in the CS group 
(OR = 1.51, 95% CI = 1.00-2.27, p = 0.05, I2 = 52%). No reflow occurred in 6.6% in DS group compared to 6.9% in the CS group (OR = 0.78, 95% 
CI = 0.39-1.55, p = 0.48, I2 = 0%). 
Conclusion: Small trials suggest a potential benefit to DS in acute MI. Further large scale randomized trials are warranted to confirm the benefit of 
this approach.
 
